18 and older, any sex, with School-based Mental Health Treatment Services. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Clinician Acceptability of MBCPrimary· Baseline, 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Acceptability of Intervention Measure (e.g., a score of 5 = completely agree and is most favorable; possible scores range from 1-5)
Baseline
Group
Value
95% CI
Measurement-based Care Year 1
3.96
± 0.65
Measurement-based Care Year 2
3.52
± 0.95
3-month
Group
Value
95% CI
Measurement-based Care Year 1
4.54
± 0.51
Measurement-based Care Year 2
3.58
± 0.87
6-month
Group
Value
95% CI
Measurement-based Care Year 1
4.64
± 0.63
9-month
Group
Value
95% CI
Measurement-based Care Year 1
4.56
± 0.51
Measurement-based Care Year 2
3.76
± 0.75
Change in Clinician Appropriateness of MBCPrimary· Baseline, 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Intervention Appropriateness Measure (e.g., a score of 5 = completely agree and is most favorable; possible scores range from 1-5)
Baseline
Group
Value
95% CI
Measurement-based Care Year 1
4.13
± 0.79
Measurement-based Care Year 2
3.64
± 0.87
3-month
Group
Value
95% CI
Measurement-based Care Year 1
4.50
± 0.55
Measurement-based Care Year 2
3.52
± 0.99
6-month
Group
Value
95% CI
Measurement-based Care Year 1
4.68
± 0.55
9-month
Group
Value
95% CI
Measurement-based Care Year 1
4.47
± 0.54
Measurement-based Care Year 2
3.93
± 0.8
Change in Clinician Feasibility of MBCPrimary· Baseline, post training, 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Feasibility of Intervention Measure (e.g., a score of 5 = completely agree and is most favorable; possible scores range from 1-5)
Baseline
Group
Value
95% CI
Measurement-based Care Year 1
3.92
± 0.48
Measurement-based Care Year 2
3.47
± 0.86
3-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.29
± 0.66
Measurement-based Care Year 2
3.45
± 0.85
6-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.07
± 1.16
9-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.08
± 0.64
Measurement-based Care Year 2
3.74
± 0.68
Change in Clinician Fidelity to MBCPrimary· 9-month follow up (end of school year; end of study period)
Monthly fidelity monitoring of ORS measures entered in the online system as evidence of administration with student or parent respondents. A count of participants meeting the established fidelity threshold of 2 or more ORS measures will be calculated each month. Possible scores range from 0-100%.
Group
Value
95% CI
Measurement-based Care Year 1
9
Measurement-based Care Year 2
12
Change in Clinician Use of MBCPrimary· Baseline, post training, 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Current Assessment Practice Evaluation - Revised (e.g., a score of 100% across all items is most favorable). Possible scores range from 0-100%.
Baseline
Group
Value
95% CI
Measurement-based Care Year 1
2.23
± 4.52
Measurement-based Care Year 2
19.60
± 17.15
3-Month
Group
Value
95% CI
Measurement-based Care Year 1
24.33
± 24.63
Measurement-based Care Year 2
9.81
± 15.37
6-Month
Group
Value
95% CI
Measurement-based Care Year 1
31.59
± 37.55
9-Month
Group
Value
95% CI
Measurement-based Care Year 1
21.29
± 23.21
Measurement-based Care Year 2
11.82
± 18.38
Change in Clinician Acceptability of the PCOMSPrimary· 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Usage Rating Profile - Assessment (e.g., a score of 6 = strongly agree and is most favorable; possible scores range from 1-6. )
3-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.62
± 0.51
Measurement-based Care Year 2
3.69
± 0.78
6-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.70
± 0.54
9-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.38
± 0.59
Measurement-based Care Year 2
3.95
± 0.70
Change in Clinician Attitudes Toward Standardized AssessmentPrimary· Baseline, 3-month follow up, 6-month follow up, 9-month follow up
Change in clinician-reported Attitudes toward Standardized Assessment-Monitoring and Feedback Scale (e.g., a score of 5 = strongly agree across is most favorable; possible scores range from 1-5)
Baseline
Group
Value
95% CI
Measurement-based Care Year 1
3.65
± 0.63
Measurement-based Care Year 2
3.33
± 0.59
3-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.31
± 0.38
Measurement-based Care Year 2
3.36
± 0.70
6-Month
Group
Value
95% CI
Measurement-based Care Year 1
4.21
± 0.48
9-Month
Group
Value
95% CI
Measurement-based Care Year 1
3.98
± 0.57
Measurement-based Care Year 2
3.49
± 0.65
Sponsor's own description
The purpose of the study is to examine the implementation outcomes (i.e., feasibility, appropriateness, acceptability, and fidelity) of MBC in school-based mental health treatment services. The investigators plan to observe the effectiveness of MBC on student engagement and treatment outcomes as a secondary goal. This pilot implementation-effectiveness trial is designed to inform a future, large-scale trial with more participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking
· Phase 2
· not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing
· NA
· not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S
· NA
· not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa
· Phase 1, PHASE2
· not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 14 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039671.